About the Conference

Arrowhead Publishers is pleased to announce the return of its 6th Annual Translational Microbiome Conference to Boston on April 21-23, 2020, taking place at the Westin Copley Place. As the official conference of The Microbiome Coalition (TMBC), the Arrowhead Translational Microbiome Conference was the first microbiome conference in the field to focus exclusively on the hurdles and challenges to commercial success in the space.

 

Once again, the conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Expanding on this core focus year on year, we continue to offer informative, hands-on workshops, panels sponsored and directed by industry to focus on your concerns and tightly curated content that goes beyond the usual infomercials to provide tangible and useful insights to how your peers are addressing their commercial approach to the space.

 

Entering its 6th year in 2020, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.

 

Download a Brochure                  Join Our Mailing List

 

Why Attend?

  • Partnering Software & Meetings

  • Easily schedule meetings with our partnering system in order to maximize your time at the event. Schedule one-to-one meetings in advance and stay connected after the event.

  • Industry-Leading Speaking Faculty

  • Our tightly curated content provides tangible and useful insights to how your peers are addressing their scientific, clinical and commercial approach to the space.

  • Network With Industry Colleagues

  • One-to-One meeting space, breakfasts, extended breaks, luncheons and receptions provide attendees with multiple opportunities to connect with colleagues in the space.

  • 20+ Exhibitors/Service Providers

  • Meet with and/or re-connect with exhibitors and service providers and learn about the latest tools and resources driving the field of microbiome science.

 

REQUEST SPONSORSHIP PROSPECTUS

2020 Featured Speakers

    • Shahram Lavasani, Ph.D.

    • Founder, CEO/CSO
    • Immune Biotech

Olle_Bernat.jpg

    • Scott Jackson, Ph.D.

    • Group Leader, Complex Microbial Systems
    • NIST (National Institute of Standards & Technology)

Solomon_Jeffrey.png

    • Rachel Clemens, Ph.D.

    • Commercial Innovation Manager, Life Science Lead
    • ISS US National Lab, Center for Advancement in Science in Space

Smith_Mark1.jpg

    • Lynne Elmore, Ph.D.

    • Director, Translational Cancer Research Program
    • American Cancer Society

    • Garth Ehrlich, Ph.D.

    • Professor of Microbiology & Immunology, Professor of Otolayngology - Head & Neck Surgery
    • Drexel University College of Medicine

Olle_Bernat.jpg

    • Momo Vuyisch, Ph.D.

    • Chief Scientific Officer
    • Viome

Solomon_Jeffrey.png

    • Nancy Caralla

    • Foundiing President, Executive Director
    • C Diff Foundation

Smith_Mark1.jpg

    • Rachel Teitelbaum, Ph.D.

    • Chief Executive Officer
    • Hervana

SEE THE FULL SPEAKING FACULTY TO DATE

Testimonials

Great conference, high-quality talks. Congrats on organizing such an event!

Conference Attendee
Computational Biologist , Memorial Sloan Kettering Cancer Center

It was a fantastic conference, and I truly got a lot out of hearing from and speaking with the diverse range of speakers and attendees. It’s really a great event and I’m glad to have been a part... Read More

Elliot Friedman
Technical Director, PennCHOP Microbiome Program , University of Pennsylvania

An excellent meeting where the excitement and challenges in microbiome research are presented. Well balanced in translational microbiome research, ethical issues, and investment opportunities and... Read More

Seyoum Ayehunie
VP of Immunological Systems , Mattek

A great diversity of subjects and depths were covered so both experts and new-comers had sessions they could gain insights from. The mix of subjects brings the field together and helps build the... Read More

Dale Pfost
CEO , Microbiome Therapeutics

This is an excellent conference to get updated in the field and at the same time connect with other players in this exciting field.

Morten Isaksen
CEO , Bio-Me

It’s the perfect blend of science and industry. A diverse and amazing group of people in one of the fastest-growing and most promising fields.

Stephen Skolnick
Founder , Mood Nutraceuticals

This is my third year attending the conference and it gets better every year. The diverse topics, great speakers, with latest research findings and targeted workshops and panel discussion. Would... Read More

Ying Chen
Research & Development Manager , Reckitt Benckiser

My second experience with such a meeting, but night and day difference! Very informative and of high standard

Pinaki Panigrahi
Professor , University of Nebraska Medical Center

An excellent meeting where the excitement and challenges in microbiome research are presented. Well balanced in translational microbiome research, ethical issues, and investment opportunities and... Read More

Seyoum Ayehunie
Vice President of Immunological Systems , Mattek

Great mix of microbiomics science, pharmaceutical development and networking

Tarik Alhmaud
Physician , University of New Mexico

For someone with a nascent interest in the microbiome, this conference has been an extremely transformative experience

Dalton Price
Founder and Executive Director , YouResearch

Very well organized and focused group

Gerardo Toledo
Consultant

The conference was educational both in terms of exposing me to the current microbiome-related science as well as the several aspects of running a business in this field

Sneha Jani
Ph.D. Student , Texas A&M University

Overall, it was a great conference. As a student, some of the business discussions were above my head, but I had a really great experience

Anand Kumar
PostDoc , Los Alamos National Lab

I'm a Research Associate at a startup and was able to gather lots of information that will inform establishment of our NGS core

Conference Attendee

A great immersion into the microbiome space with competent speakers and engaging attendees

Conference Attendee

Good mix of topics and speakers

Conference Attendee

Broad spectrum, background for profound understanding

Conference Attendee

Liked the diversity of presenters and attendees, presentation length was good and well-run

Conference Attendee

Really appreciated the equity and range in gender, expertise, and age of speakers

Conference Attendee

Great representation of topics and perspectives

Conference Attendee

Developed a number of new relationships

Conference Attendee

Diverse audience and speakers—scientist and business aspects

Conference Attendee

Very informative and exciting conference, learned a lot and fostered new ideas. Really glad I came!

Conference Attendee

Great panel, great speakers, crowd was ideal size

Conference Attendee

Venue

The Westin Copley Place
10 Huntington Avenue
Boston, MA 02116 USA
Phone: 617-262-9600

A guest room block is available for attendees, exhibitors and speakers. CLICK HERE to book your room.

 

Who Should Attend

Organizations:

Academic Institutions, Biopharma Companies, Diagnostics Companies and Investors

Professions:

Healthcare Professionals, Physicians, Clinical Development Professionals, Biopharma Business Leaders, Researchers, Professors

Job Titles:

VPs, Directors, Heads, Scientists, Professors in following areas: 

  • Microbiome / Microbiota basic research

  • NGS (Next Generation Sequencing)

  • Molecular Diagnostics

  • Autoimmune Disease Therapeutics

  • Infectious Diseases

  • Metabolic disease, Obesity, Diabetes

  • Genotyping

  • Genomics

  • Genomic Profiling

  • Biomarkers

  • Immunology Innate or Adaptive Immunity

  • Bioinformatics

  • Data Management

  • Data Analysis

  • Molecular Biology

  • Diagnostic & Clinical Applications

  • Prenantal Diagnostics

  • Vaccines

  • Microbiology

  • Food / Nutrition Science

  • Gut-Brain Axis Researchers

  • Venture Capitalists

  • Biotech Entrepreneurs

  • Academic Licensing or Tech Transfer Officers

  • Business Development / In-Licensing

  • FDA regulation

  • Clinical trials

  • Epigenetics

  • Metagenomics

  • High-Throughput Technologies

  • Data Analysis

  • Data Storage

  • Cloud Computing

  • Statistical Genomics

Joint-Providership Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Office of Continuing Medical Education of the University of Virginia School of Medicine and Arrowhead Publishers. The Office of Continuing Medical Education of the University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians

The University of Virginia School of Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity. (The number of credits offered for this event is subject to change dependent upon future additions/revisions to the agenda.)

The University of Virginia School of Medicine, as accredited provider, awards 8 hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)TM ) to a participant who successfully completes this educational activity. The University of Virginia School of Medicine maintains a record of participation for six (6) years.

About Us

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward. Learn more about us at www.arrowheadpublishers.com.

Contact Us

Arrowhead Publishers & Conferences
PO Box 96
7730 Laredo Drive, #96
Chanhassen, MN 55317
866-945-0263
enquiries@arrowheadpublishers.com

PRIVACY POLICY

Continuing Medical Education Credits Now Available for this Event

Joint-Providership Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Office of Continuing Medical Education of the University of Virginia School of Medicine and Arrowhead Publishers. The Office of Continuing Medical Education of the University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians

The University of Virginia School of Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity. (The number of credits offered for this event is subject to change dependent upon future additions/revisions to the agenda.)

The University of Virginia School of Medicine, as accredited provider, awards 8 hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)TM ) to a participant who successfully completes this educational activity. The University of Virginia School of Medicine maintains a record of participation for six (6) years.

Shahram Lavasani, Ph.D.

Founder, Chief Executive Officer and Chief Scientific Officer
Immune Biotech

Profile coming soon.

Scott Jackson, Ph.D.

Group Leader, Complex Microbial Systems
NIST (National Institute of Standards & Technology

Profile coming soon.

Rachel Clemens, Ph.D.

Commerical Innovation Manager, Life Science Lead
ISS US National Lab, Center for Advancement in Science in Space

Profile coming soon.

Lynne Elmore, Ph.D.

Director, Translational Cancer Research Program
American Cancer Society

Lynne Elmore, PhD, is the director of the Translational Cancer Research program in the Extramural Grants department of the American Cancer Society (ACS). She manages a research portfolio focused on cell biology, infectious disease, the microbiome, molecular genetics, and cancer drug discovery.

Garth Ehrlich, Ph.D.

Professor of Microbiology & Immunology, Professor of Otolayngology - Head & Neck Surgery
Drexel University College of Medicine

Dr Ehrlich is Professor of Microbiology and Immunology, and Otolaryngology-Head and Neck Surgery at Drexel University College of Medicine (DUCOM) in Philadelphia, PA, USA. Dr. Ehrlich is also the founder and director of three Research Centers of Excellence in the Institute for Molecular Medicine and Infectious Disease: the Center for Genomic Sciences (CGS); the Center for Advanced Microbial Processing (CAMP); and the Center for Surgical Infections and Biofilms.

He also directs Drexel University’s Core Genomics Facility and the Meta-Omics Shared Resource for the Sidney Kimmel Cancer Center – an NCI-designated Cancer Center.

Momo Vuyisich, Ph.D.

Chief Scientific Officer
Viome

Momo Vuyisich is a co-founder and Chief Science Officer at Viome, a data-driven personalized nutrition company. Momo provides scientific leadership at Viome and his vision is to revolutionize healthcare from "symptoms management" to a true preventative medicine. He leads product development, clinical test implementation, and comprehensive clinical research portfolio.

Momo is also an Adjunct Professor at the University of New Mexico and New Mexico Tech. Before co-founding Viome in 2016, Momo spent 12 years at Los Alamos National Laboratory, where he led the Applied Genomics team, which developed the core technology used by Viome today.

Nancy Caralla

Founding President, Executive Director
C Diff Foundation

Nancy C Caralla is a three-time Clostridioides difficile infection (CDI) survivor. She has accumulated over 25 years of experience in the nursing profession blended with over 30 years in international construction management. Over the past several years, Nancy, in partnership with C Diff Foundation members, has focused on raising C. difficile awareness through education and advocating for Clostridium difficile infection prevention, treatments, clinical trials, AMR, and environmental safety worldwide. The C Diff Foundation is a non-profit organization that takes great pride in its volunteers, chairpersons, and committees.

Rachel Teitelbaum, Ph.D.

Chief Executive Officer
Hervana

Profile coming soon.

Sonia Timerlake, Ph.D.

Vice President of Research
Finch Therapeutics

Dr. Sonia Timberlake is the VP of Research at Finch Therapeutics, a microbiome therapeutics company. Sonia is an expert at designing NGS-based algorithms for applications in microbial genomics, immunogenomics, and evolution. Prior to joining Finch, she built and managed AbVitro's computational algorithms and infrastructure, supporting high throughput single-cell immune phenotyping and repertoire sequencing technology. This technology platform was acquired by Juno Therapeutics, where Sonia led a multidisciplinary team to harness native adaptive immune responses for developing engineered cell therapies in oncology.

Dae-Wook Kang, Ph.D.

Assistant Professor, Department of Civil & Environmental Engineering
University of Toledo

Profile coming soon.

Sameer Sonkusale, Ph.D.

Prof. of Electrical & Computer Engineering, Prof. of Biomedical Engineering (adjunct), Director/Principal Investigator, Nano Lab
Tufts University

Profile coming soon.

Amy Feehan, Ph.D.

Research Scientist
Ochsner Health System

Dr. Feehan is an early stage investigator who received her BS and PhD in Neuroscience from The Brain Institute at Tulane University in New Orleans. She has conducted research in humans and rodents covering topics ranging from drug development of novel endomorphin analogs for pain, to sleep and circadian rhythms research and most recently the gut-brain axis and infectious disease. Her doctoral work led to two patents for a compound that reverses both acute and chronic pain with no observable risk of addiction. She currently works as a research scientist in the Infectious Disease department at Ochsner in New Orleans designing and executing investigator-initiated clinical trials.